Submit Feedback
Recent searches
    Trending searches
    Pfizer
    +
    Revenue breakdown by Products & Services
    Revenue breakdown by Geography

    Pfizer's Revenue by Segment

    In fiscal year , Pfizer's revenue by segment (products & services) are as follows:


    Learn more about Pfizer’s Revenue by Geography

    Check out competitors to Pfizer in a side-by-side comparison.

    Explore additional financial metrics for Pfizer.

    Continue reading...

    The above chart shows Pfizer's revenue percentage share by segment (products and services).

    In fiscal year 2022, Pfizer's revenue by segment is as follows:

    • Biopharma Segment generated $8.54B in revenue, representing 100% of its total revenue.

    The biggest segment for Pfizer is the Biopharma Segment, which represents 100% of its total revenue.
    The smallest segment for Pfizer is the Biopharma Segment, which represents 100% of its total revenue.

    The above chart shows Pfizer's revenue percentage share by segment (products and services).

    In fiscal year 2023, Pfizer's revenue by segment is as follows:

    • Biopharma Segment generated $7.58B in revenue, representing 100% of its total revenue.

    The biggest segment for Pfizer is the Biopharma Segment, which represents 100% of its total revenue.
    The smallest segment for Pfizer is the Biopharma Segment, which represents 100% of its total revenue.
    Continue reading...

    Summary Table

    Products & Services (Percent Share) 2022 2023 2024
    Biopharma Segment 100% 100% -
    Total Revenue 100% 100% 100%

    The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.

  • Biopharma Segment revenue decreased -100% ($7.58B) from $7.58B (in 2023) to $0.00 (in 2024).
    • Continue reading...

    Summary Table

    Products & Services 2022
    Value Change
    		2023
    Value Change
    		2024
    Value Change
    Biopharma Segment $8.54B - $7.58B
    11.19%
    		- -
    Total Revenue $8.54B - $7.58B
    11.19%
    		-
    100.00%

    Related company

    Related